Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Immunogenicity, safety and reactogenicity of GSK Biologicals' influenza vaccine GSK1247446A with various formulations in subjects aged 18-64 years
Influenza Vaccine
110794
NCT00540228
Influenza
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
May 2013

Powered by ideaPoint, Inc.